Active Shortage

JAMP-DOXAZOSIN

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of JAMP-DOXAZOSIN in Canada?

Yes. JAMP-DOXAZOSIN 1MG has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is JAMP-DOXAZOSIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will JAMP-DOXAZOSIN be available again?

The manufacturer's estimated resolution date is January 22, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~2 months remaining (estimate)

Affected strength1MG

Report last updated2026-11-05

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

APO-DOXAZOSIN

APOTEX INC

1MG · DIN 02240588

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TEVA-DOXAZOSIN

TEVA CANADA LIMITED

4MG · DIN 02242730

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

JAMP-DOXAZOSIN

JAMP PHARMA CORPORATION

2MG · DIN 02489945

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

JAMP-Doxazosin 4 mg

JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification in the affected lot.

Type II2024-06-25

Moderate health risk

Possible match — not confirmed

DIN

02489937

Strength

1MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

DOXAZOSIN

See all DOXAZOSIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-11-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

AMLODIPINE

5MG · DIN 02429217

AMLODIPINE

2.5MG · DIN 02492199

AMLODIPINE

10MG · DIN 02429225